SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bausch & Lomb Corp. – ‘10-K’ for 12/31/23 – ‘EX-97’

On:  Wednesday, 2/21/24, at 4:55pm ET   ·   For:  12/31/23   ·   Accession #:  1860742-24-4   ·   File #:  1-41380

Previous ‘10-K’:  ‘10-K’ on 2/22/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   16 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/21/24  Bausch & Lomb Corp.               10-K       12/31/23  148:18M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   3.64M 
 2: EX-10.28    Material Contract                                   HTML    107K 
 3: EX-21.1     Subsidiaries List                                   HTML     57K 
 4: EX-23.1     Consent of Expert or Counsel                        HTML     39K 
 9: EX-97       Clawback Policy re: Recovery of Erroneously         HTML     72K 
                Awarded Compensation                                             
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     43K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     43K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     41K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     41K 
15: R1          Document and Entity Information                     HTML    107K 
16: R2          Audit Information                                   HTML     44K 
17: R3          Consolidated Balance Sheets                         HTML    158K 
18: R4          Consolidated Balance Sheets (Parenthetical)         HTML     45K 
19: R5          Consolidated Statements of Operations               HTML    132K 
20: R6          Consolidated Statements of Comprehensive (Loss)     HTML     89K 
                Income                                                           
21: R7          Consolidated Statements of Shareholders' Equity     HTML    109K 
22: R8          Consolidated Statements of Cash Flows               HTML    148K 
23: R9          Description of Business                             HTML     47K 
24: R10         Significant Accounting Policies                     HTML    173K 
25: R11         Related Parties                                     HTML     69K 
26: R12         Acquisitions and Licensing Agreements               HTML     91K 
27: R13         Fair Value Measurements                             HTML    121K 
28: R14         Inventories                                         HTML     48K 
29: R15         Property, Plant and Equipment                       HTML     53K 
30: R16         Intangible Assets and Goodwill                      HTML    123K 
31: R17         Accrued and Other Current Liabilities               HTML     51K 
32: R18         Financing Arrangements                              HTML     93K 
33: R19         Pension and Postretirement Employee Benefit Plans   HTML    324K 
34: R20         Leases                                              HTML     68K 
35: R21         Share-Based Compensation                            HTML    118K 
36: R22         Accumulated Other Comprehensive Loss                HTML     48K 
37: R23         Research and Development                            HTML     50K 
38: R24         Other Expense, Net                                  HTML     61K 
39: R25         Income Taxes                                        HTML    138K 
40: R26         Earnings Per Share                                  HTML     60K 
41: R27         Supplemental Cash Flow Disclosures                  HTML     48K 
42: R28         Legal Proceedings                                   HTML     76K 
43: R29         Commitments and Contingencies                       HTML     46K 
44: R30         Segment Information                                 HTML    174K 
45: R31         Significant Accounting Policies (Policies)          HTML    234K 
46: R32         Significant Accounting Policies (Tables)            HTML     90K 
47: R33         Related Parties (Tables)                            HTML     52K 
48: R34         Acquisitions and Licensing Agreements (Tables)      HTML     75K 
49: R35         Fair Value Measurements (Tables)                    HTML    123K 
50: R36         Inventories (Tables)                                HTML     49K 
51: R37         Property, Plant and Equipment (Tables)              HTML     52K 
52: R38         Intangible Assets and Goodwill (Tables)             HTML    158K 
53: R39         Accrued and Other Current Liabilities (Tables)      HTML     50K 
54: R40         Financing Arrangements (Tables)                     HTML     71K 
55: R41         Pension and Postretirement Employee Benefit Plans   HTML    324K 
                (Tables)                                                         
56: R42         Leases (Tables)                                     HTML     74K 
57: R43         Share-Based Compensation (Tables)                   HTML    107K 
58: R44         Accumulated Other Comprehensive Loss (Tables)       HTML     47K 
59: R45         Research and Development (Tables)                   HTML     49K 
60: R46         Other Expense, Net (Tables)                         HTML     56K 
61: R47         Income Taxes (Tables)                               HTML    142K 
62: R48         Earnings Per Share (Tables)                         HTML     56K 
63: R49         Supplemental Cash Flow Disclosures (Tables)         HTML     47K 
64: R50         Segment Information (Tables)                        HTML    173K 
65: R51         DESCRIPTION OF BUSINESS - Narrative (Details)       HTML     54K 
66: R52         SIGNIFICANT ACCOUNTING POLICIES - Narrative         HTML    122K 
                (Details)                                                        
67: R53         SIGNIFICANT ACCOUNTING POLICIES - Activity in       HTML     49K 
                Allowance for Credit Losses (Details)                            
68: R54         SIGNIFICANT ACCOUNTING POLICIES - Property, Plant   HTML     55K 
                and Equipment (Details)                                          
69: R55         SIGNIFICANT ACCOUNTING POLICIES - Intangible        HTML     53K 
                Assets (Details)                                                 
70: R56         SIGNIFICANT ACCOUNTING POLICIES - Revenue           HTML     62K 
                Recognition, Variable Consideration Provisions                   
                (Details)                                                        
71: R57         RELATED PARTIES - Narrative (Details)               HTML     92K 
72: R58         RELATED PARTIES - Schedule of Net Transfers         HTML     53K 
                (Details)                                                        
73: R59         ACQUISITIONS AND LICENSING AGREEMENTS - 2023        HTML    139K 
                Acquisitions, Narrative (Details)                                
74: R60         ACQUISITIONS AND LICENSING AGREEMENTS - Aggregate   HTML     49K 
                Acquisition Consideration (Details)                              
75: R61         ACQUISITIONS AND LICENSING AGREEMENTS - Assets      HTML     61K 
                Acquired and Liabilities Assumed (Details)                       
76: R62         ACQUISITIONS AND LICENSING AGREEMENTS - Intangible  HTML     52K 
                Assets Acquired (Details)                                        
77: R63         ACQUISITIONS AND LICENSING AGREEMENTS - Pro Forma   HTML     46K 
                Information (Details)                                            
78: R64         ACQUISITIONS AND LICENSING AGREEMENTS - Intangible  HTML     52K 
                Assets Acquired, Asset Acquisition (Details)                     
79: R65         ACQUISITIONS AND LICENSING AGREEMENTS - 2022        HTML     68K 
                Licensing Agreement and Acquisitions, Narrative                  
                (Details)                                                        
80: R66         FAIR VALUE MEASUREMENTS - Assets and Liabilities    HTML     90K 
                Measured at Fair Value on a Recurring Basis                      
                (Details)                                                        
81: R67         FAIR VALUE MEASUREMENTS - Narrative (Details)       HTML     72K 
82: R68         FAIR VALUE MEASUREMENTS - Cross-currency Swaps      HTML     57K 
                Included in Condensed Consolidated Balance Sheets                
                (Details)                                                        
83: R69         FAIR VALUE MEASUREMENTS - Cross-currency Swaps,     HTML     51K 
                Effect of Hedging Instruments on Financial                       
                Instruments (Details)                                            
84: R70         FAIR VALUE MEASUREMENTS - Foreign Currency          HTML     62K 
                Exchange Contracts Included in Condensed                         
                Consolidated Balance Sheets (Details)                            
85: R71         FAIR VALUE MEASUREMENTS - Foreign Currency          HTML     49K 
                Exchange Contracts Effect of Hedging Instruments                 
                on Financial Instruments (Details)                               
86: R72         FAIR VALUE MEASUREMENTS - Assets and Liabilities    HTML     62K 
                Measured at Fair Value on a Recurring Basis Using                
                Significant Unobservable Inputs (Level3) (Details)               
87: R73         INVENTORIES - Components of Inventories (Details)   HTML     47K 
88: R74         INVENTORIES - Narrative (Details)                   HTML     41K 
89: R75         PROPERTY, PLANT AND EQUIPMENT - Major Components    HTML     59K 
                of Property, Plant, and Equipment (Details)                      
90: R76         PROPERTY, PLANT AND EQUIPMENT - Narrative           HTML     41K 
                (Details)                                                        
91: R77         INTANGIBLE ASSETS AND GOODWILL - Major Components   HTML     74K 
                of Intangible Assets (Details)                                   
92: R78         INTANGIBLE ASSETS AND GOODWILL - Narrative          HTML     71K 
                (Details)                                                        
93: R79         INTANGIBLE ASSETS AND GOODWILL - Amortization       HTML     55K 
                Expense (Details)                                                
94: R80         INTANGIBLE ASSETS AND GOODWILL - Changes in         HTML     65K 
                Carrying Amount of Goodwill (Details)                            
95: R81         ACCRUED AND OTHER CURRENT LIABILITIES - Summary of  HTML     53K 
                Accrued and Other Current Liabilities (Details)                  
96: R82         FINANCING ARRANGEMENTS - Summary of Long-term Debt  HTML     72K 
                (Details)                                                        
97: R83         FINANCING ARRANGEMENTS - Narrative (Details)        HTML    165K 
98: R84         FINANCING ARRANGEMENTS - Maturities of Long-Term    HTML     66K 
                Debt (Details)                                                   
99: R85         PENSION AND POSTRETIREMENT EMPLOYEE BENEFIT PLANS   HTML     77K 
                - Narrative (Details)                                            
100: R86         PENSION AND POSTRETIREMENT EMPLOYEE BENEFIT PLANS   HTML     53K  
                - Amounts Recognized in Accumulated Other                        
                Comprehensive Loss (Details)                                     
101: R87         PENSION AND POSTRETIREMENT EMPLOYEE BENEFIT PLANS   HTML     73K  
                - Components of Net Periodic Benefit Cost                        
                (Details)                                                        
102: R88         PENSION AND POSTRETIREMENT EMPLOYEE BENEFIT PLANS   HTML    117K  
                - Change in Benefit Obligation, Plan Assets and                  
                Funded Status (Details)                                          
103: R89         PENSION AND POSTRETIREMENT EMPLOYEE BENEFIT PLANS   HTML     52K  
                - Underfunded Plans (Details)                                    
104: R90         PENSION AND POSTRETIREMENT EMPLOYEE BENEFIT PLANS   HTML     62K  
                - Future Benefit Payments for the Pension Benefit                
                Plans (Details)                                                  
105: R91         PENSION AND POSTRETIREMENT EMPLOYEE BENEFIT PLANS   HTML     70K  
                - Weighted-Average Assumptions Used to Determine                 
                Net Periodic Benefit Costs and Benefit Obligations               
                (Details)                                                        
106: R92         PENSION AND POSTRETIREMENT EMPLOYEE BENEFIT PLANS   HTML     57K  
                - Actual Asset Allocations (Details)                             
107: R93         PENSION AND POSTRETIREMENT EMPLOYEE BENEFIT PLANS   HTML    125K  
                - Fair Value of Pension and Postretirement Benefit               
                Plan Assets Assumed in Connection with the                       
                Acquisition (Details)                                            
108: R94         LEASES - Right-of-use Assets and Right-of-use       HTML     56K  
                Liabilities (Details)                                            
109: R95         LEASES - Narrative (Details)                        HTML     45K  
110: R96         LEASES - Lease Expenses (Details)                   HTML     43K  
111: R97         LEASES - Lease Additional Information (Details)     HTML     48K  
112: R98         LEASES - Lease Future Payments (Details)            HTML     62K  
113: R99         SHARE-BASED COMPENSATION - 2022 Omnibus Incentive   HTML    157K  
                Plan (Details)                                                   
114: R100        SHARE-BASED COMPENSATION - Summary of Share-based   HTML     51K  
                Compensation Expense (Details)                                   
115: R101        SHARE-BASED COMPENSATION - Stock Options (Details)  HTML    140K  
116: R102        SHARE-BASED COMPENSATION - Time-Based RSUs          HTML    101K  
                (Details)                                                        
117: R103        SHARE-BASED COMPENSATION - Performance-Based RSUs   HTML    113K  
                (Details)                                                        
118: R104        ACCUMULATED OTHER COMPREHENSIVE LOSS - Summary of   HTML     63K  
                Components of Accumulated Other Comprehensive Loss               
                (Details)                                                        
119: R105        RESEARCH AND DEVELOPMENT - Summary of Research and  HTML     45K  
                Development (Details)                                            
120: R106        OTHER EXPENSE, NET - Summary of Other Expense, Net  HTML     57K  
                (Details)                                                        
121: R107        OTHER EXPENSE, NET - Narrative (Details)            HTML     53K  
122: R108        INCOME TAXES - Components of Income Before          HTML     74K  
                (Provision for) Benefit from Income Taxes                        
                (Details)                                                        
123: R109        INCOME TAXES - Schedule of Effective Income Tax     HTML     74K  
                Reconciliation (Details)                                         
124: R110        INCOME TAXES - Tax Effect of Major Items Recorded   HTML     67K  
                as Deferred Tax Assets and Liabilities (Details)                 
125: R111        INCOME TAXES - Schedule of Reconciliation of        HTML     50K  
                Deferred Tax Asset Valuation Allowance (Details)                 
126: R112        INCOME TAXES - Narrative (Details)                  HTML     65K  
127: R113        INCOME TAXES - Federal Income Tax Returns by        HTML     59K  
                Jurisdiction (Details)                                           
128: R114        INCOME TAXES - Reconciliation Schedule of           HTML     51K  
                Unrecognized Tax Benefits (Details)                              
129: R115        EARNINGS PER SHARE - Narrative (Details)            HTML     63K  
130: R116        EARNINGS PER SHARE - Schedule of Calculation of     HTML     74K  
                Earnings Per Share (Details)                                     
131: R117        SUPPLEMENTAL CASH FLOW DISCLOSURES - Schedule of    HTML     44K  
                Supplemental Cash Flow Disclosures (Details)                     
132: R118        SUPPLEMENTAL CASH FLOW DISCLOSURES - Narrative      HTML     46K  
                (Details)                                                        
133: R119        LEGAL PROCEEDINGS - Legal Proceedings (Details)     HTML     41K  
134: R120        LEGAL PROCEEDINGS - Product Liability (Details)     HTML     57K  
135: R121        LEGAL PROCEEDINGS - General Civil Actions           HTML     53K  
                (Details)                                                        
136: R122        LEGAL PROCEEDINGS - Intellectual Property Matters   HTML     58K  
                (Details)                                                        
137: R123        COMMITMENTS AND CONTINGENCIES - Narrative           HTML     45K  
                (Details)                                                        
138: R124        SEGMENT INFORMATION - Segment Revenues and Profit   HTML     81K  
                (Details)                                                        
139: R125        SEGMENT INFORMATION - Capital Expenditures Paid     HTML     53K  
                (Details)                                                        
140: R126        SEGMENT INFORMATION - Disaggregation of Revenue     HTML     81K  
                (Details)                                                        
141: R127        SEGMENT INFORMATION - Narrative (Details)           HTML     50K  
142: R128        SEGMENT INFORMATION - Revenue by Geographic Area    HTML     75K  
                (Details)                                                        
143: R129        SEGMENT INFORMATION - Geographical Information,     HTML     60K  
                Long-Lived Assets (Details)                                      
145: XML         IDEA XML File -- Filing Summary                      XML    275K  
148: XML         XBRL Instance -- blco-20231231_htm                   XML   4.78M  
144: EXCEL       IDEA Workbook of Financial Report Info              XLSX    323K  
11: EX-101.CAL  XBRL Calculations -- blco-20231231_cal               XML    340K 
12: EX-101.DEF  XBRL Definitions -- blco-20231231_def                XML   1.63M 
13: EX-101.LAB  XBRL Labels -- blco-20231231_lab                     XML   3.20M 
14: EX-101.PRE  XBRL Presentations -- blco-20231231_pre              XML   2.23M 
10: EX-101.SCH  XBRL Schema -- blco-20231231                         XSD    353K 
146: JSON        XBRL Instance as JSON Data -- MetaLinks              825±  1.28M  
147: ZIP         XBRL Zipped Folder -- 0001860742-24-000004-xbrl      Zip    964K  


‘EX-97’   —   Clawback Policy re: Recovery of Erroneously Awarded Compensation


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  
Exhibit 97

image.jpg



BAUSCH + LOMB CORPORATION
FINANCIAL RESTATEMENT COMPENSATION RECOUPMENT POLICY
        This Bausch + Lomb Corporation Financial Restatement Compensation Recoupment Policy (the “Policy”) has been adopted by the Board of Directors (the “Board”) of Bausch + Lomb Corporation (the “Company”) on July 24, 2023. This Policy provides for the recoupment of certain executive compensation in the event of an accounting restatement resulting from material noncompliance with financial reporting requirements under U.S. federal securities laws in accordance with the terms and conditions set forth herein. This Policy is intended to comply with the requirements of Section 10D of the Exchange Act (as defined below) and Section 303A.14 of the NYSE Listed Company Manual.

1.Definitions. For the purposes of this Policy, the following terms shall have the meanings set forth below.

(a)Committee” means the Talent and Compensation Committee of the Board or any successor committee thereof. If there is no compensation committee of the Board, references herein to the Committee shall refer to the Company’s committee of independent directors that is responsible for executive compensation decisions, or in the absence of such a compensation committee, the independent members of the Board.

(b)Covered Compensation” means any Incentive-based Compensation “received” by a Covered Executive during the applicable Recoupment Period; provided that:

    (i) such Covered Compensation was received by such Covered Executive (A) after the Effective Date, (B) after he or she commenced service as an Executive Officer and (C) while the Company had a class of securities publicly listed on a United States national securities exchange; and
    
    (ii) such Covered Executive served as an Executive Officer at any time during the performance period applicable to such Incentive-based Compensation.

For purposes of this Policy, Incentive-based    Compensation is “received” by a Covered Executive during the fiscal period in which the Financial Reporting Measure applicable to such Incentive-based Compensation (or portion thereof) is attained, even if the payment or grant of such Incentive-based Compensation is made thereafter.

(c)Covered Executive” means any (i) current or former Executive Officer and (ii) any other employee of the Company and its subsidiaries designated by the Committee as subject to this Policy from time to time.
(d)Effective Date” means the date on which Section 303A.14 of the NYSE Listed Company Manual becomes effective.

(e)Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended.

(f)Executive Officer” means, with respect to the Company, (i) its president, (ii) its principal financial officer, (iii) its principal accounting officer (or if there is no such accounting officer, its controller), (iv) any vice-president in charge of a principal business unit, division or
    


function (such as sales, administration or finance), (v) any other officer who performs a policy-making function for the Company (including any officer of the Company’s parent(s) or subsidiaries if they perform policy-making functions for the Company) and (vi) any other person who performs similar policy-making functions for the Company. Policy-making function is not intended to include policy-making functions that are not significant. The determination as to an individual’s status as an Executive Officer shall be made by the Committee and such determination shall be final, conclusive and binding on such individual and all other interested persons.
(g)Financial Reporting Measure” means any (i) measure that is determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, (ii) stock price measure or (iii) total shareholder return measure (and any measures that are derived wholly or in part from any measure referenced in clause (i), (ii) or (iii) above). For the avoidance of doubt, any such measure does not need to be presented within the Company’s financial statements or included in a filing with the U.S. Securities and Exchange Commission to constitute a Financial Reporting Measure.
(h)Financial Restatement” means a restatement of the Company’s financial statements due to the Company’s material noncompliance with any financial reporting requirement under U.S. federal securities laws that is required in order to correct:
(i)an error in previously issued financial statements that is material to the previously issued financial statements; or
(ii)     an error that would result in a material misstatement if (A) the error were corrected in the current     period or (B) left uncorrected in the current period.

For purposes of this Policy, a Financial Restatement shall not be deemed to occur in the event of a revision of the Company’s financial statements due to an out-of-period adjustment (i.e., when the error is immaterial to the previously issued financial statements and the correction of the error is also immaterial to the current period) or a retrospective (1) application of a change in accounting principles; (2) revision to reportable segment information due to a change in the structure of the Company’s internal organization; (3) reclassification due to a discontinued operation; (4) application of a change in reporting entity, such as from a reorganization of entities under common control; or (5) revision for stock splits, reverse stock splits, stock dividends or other changes in capital structure.

(j)Incentive-based Compensation” means any compensation (including, for the avoidance of doubt, any cash or equity or equity-based compensation, whether deferred or current) that is granted, earned and/or vested based wholly or in part upon the achievement of a Financial Reporting Measure. For purposes of this Policy, “Incentive-based Compensation” shall also be deemed to include any amounts which were determined based on (or were otherwise calculated by reference to) Incentive-based Compensation (including, without limitation, any amounts under any long-term disability, life insurance or supplemental retirement or severance plan or agreement or any notional account that is based on Incentive-based Compensation, as well as any earnings accrued thereon).
(k)NYSE” means the New York Stock Exchange, or any successor thereof.

(l)Recoupment Period” means the three fiscal years completed immediately preceding the date of any applicable Recoupment Trigger Date. Notwithstanding the foregoing, the Recoupment Period additionally includes any transition period (that results from a change in the Company’s fiscal year) within or immediately following those three completed fiscal years, provided that a transition period between the last day of the Company’s previous fiscal year end

2
    


and the first day of its new fiscal year that comprises a period of nine (9) to twelve (12) months would be deemed a completed fiscal year.
(m)Recoupment Trigger Date” means the earlier of (i) the date that the Board (or a committee thereof or the officer(s) of the Company authorized to take such action if Board action is not required) concludes, or reasonably should have concluded, that the Company is required to prepare a Financial Restatement, and (ii) the date on which a court, regulator or other legally authorized body directs the Company to prepare a Financial Restatement.

2.Recoupment of Erroneously Awarded Compensation.

(a)In the event of a Financial Restatement, if the amount of any Covered Compensation received by a Covered Executive (the “Awarded Compensation”) exceeds the amount of such Covered Compensation that would have otherwise been received by such Covered Executive if calculated based on the Financial Restatement (the “Adjusted Compensation”), the Company shall reasonably promptly recover from such Covered Executive an amount equal to the excess of the Awarded Compensation over the Adjusted Compensation, each calculated on a pre-tax basis (such excess amount, the “Erroneously Awarded Compensation”).
(b) If (i) the Financial Reporting Measure applicable to the relevant Covered Compensation is stock price or total shareholder return (or any measure derived wholly or in part from either of such measures) and (ii) the amount of Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the information in the Financial Restatement, then the amount of Erroneously Awarded Compensation shall be determined (on a pre-tax basis) based on the Company’s reasonable estimate of the effect of the Financial Restatement on the Company’s stock price or total shareholder return (or the derivative measure thereof) upon which such Covered Compensation was received.
(c)For the avoidance of doubt, the Company’s obligation to recover Erroneously Awarded Compensation is not dependent on (i) if or when the restated financial statements are filed or (ii) any fault of any Covered Executive for the accounting errors or other actions leading to a Financial Restatement.
(d)Notwithstanding anything to the contrary in Sections 2(a) through (c) hereof, the Company shall not be required to recover any Erroneously Awarded Compensation if both (x) the conditions set forth in either of the following clauses (i) or (ii) are satisfied and (y) the Committee (or a majority of the independent directors serving on the Board) has determined that recovery of the Erroneously Awarded Compensation would be impracticable:

(i)the direct expense paid to a third party to assist in enforcing the recovery of the Erroneously Awarded Compensation under this Policy would exceed the amount of such Erroneously Awarded Compensation to be recovered; provided that, before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation pursuant to this Section 2(d), the Company shall have first made a reasonable attempt to recover such Erroneously Awarded Compensation, document such reasonable attempt(s) to make such recovery and provide that documentation to the NYSE; or

(ii)recovery of the Erroneously Awarded Compensation would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of Sections 401(a)(13) or 411(a) of the U.S. Internal Revenue Code of 1986, as amended (the “Code”).


3
    


(e)The Company shall not indemnify any Covered Executive, directly or indirectly, for any losses that such Covered Executive may incur in connection with the recovery of Erroneously Awarded Compensation pursuant to this Policy, including through the payment of insurance premiums or gross-up payments.

(f)The Committee shall determine, in its sole discretion, the manner and timing in which any Erroneously Awarded Compensation shall be recovered from a Covered Executive in accordance with applicable law, including, without limitation, by (i) requiring reimbursement of Covered Compensation previously paid in cash; (ii) seeking recovery of any gain realized on the vesting, exercise, settlement, sale, transfer or other disposition of any equity or equity-based awards; (iii) offsetting the Erroneously Awarded Compensation amount from any compensation otherwise owed by the Company or any of its affiliates to the Covered Executive (and for such purpose, each Covered Executive subject to this Policy agrees to the deduction of any Erroneously Awarded Compensation from any compensation payable to them by the Company or any of its Affiliates); (iv) cancelling outstanding vested or unvested equity or equity-based awards; and/or (v) taking any other remedial and recovery action permitted by applicable law. For the avoidance of doubt, except as set forth in Section 2(d), in no event may the Company accept an amount that is less than the amount of Erroneously Awarded Compensation; provided that, to the extent necessary to avoid any adverse tax consequences to the Covered Executive pursuant to Section 409A of the Code, any offsets against amounts under any nonqualified deferred compensation plans (as defined under Section 409A of the Code) shall be made in compliance with Section 409A of the Code.

3.Administration. This Policy shall be administered by the Committee. All decisions of the Committee shall be final, conclusive and binding upon the Company and the Covered Executives, their beneficiaries, executors, administrators and any other legal representative. The Committee shall have full power and authority to (i) administer and interpret this Policy, (ii) correct any defect, supply any omission and reconcile any inconsistency in this Policy and (iii) make any other determination and take any other action that the Committee deems necessary or desirable for the administration of this Policy and to comply with applicable law (including Section 10D of the Exchange Act) and applicable stock market or exchange rules and regulations. Notwithstanding anything to the contrary contained herein, to the extent permitted by Section 10D of the Exchange Act and Section 303A.14 of the NYSE Listed Company Manual, the Board may, in its sole discretion, at any time and from time to time, administer this Policy in the same manner as the Committee.

4.Amendment/Termination. Subject to Section 10D of the Exchange Act and Section 303A.14 of the NYSE Listed Company Manual, this Policy may be amended or terminated by the Committee at any time. To the extent that any applicable law, or stock market or exchange rules or regulations require recovery of Erroneously Awarded Compensation in circumstances in addition to those specified herein, nothing in this Policy shall be deemed to limit or restrict the right or obligation of the Company to recover Erroneously Awarded Compensation to the fullest extent required by such applicable law, stock market or exchange rules and regulations. Unless otherwise required by applicable law, this Policy shall no longer be effective from and after the date that the Company no longer has a class of securities publicly listed on a United States national securities exchange.

5.Interpretation. Notwithstanding anything to the contrary herein, this Policy is intended to comply with the requirements of Section 10D of the Exchange Act and Section 303A.14 of the NYSE Listed Company Manual (and any applicable regulations, administrative interpretations or stock market or exchange rules and regulations adopted in connection therewith). The provisions of this Policy shall be interpreted in a manner that satisfies such requirements and this Policy shall be operated accordingly. If any provision of this Policy would otherwise frustrate or conflict with

4
    


this intent, the provision shall be interpreted and deemed amended so as to avoid such conflict.
6.Other Compensation Clawback/Recoupment Rights. Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies, rights or requirements with respect to the clawback or recoupment of any compensation that may be available to the Company pursuant to the terms of any other recoupment or clawback policy of the Company (or any of its affiliates) that may be in effect from time to time, any provisions in any employment agreement, offer letter, equity plan, equity award agreement or similar plan or agreement, and any other legal remedies available to the Company, as well as applicable law, stock market or exchange rules, listing standards or regulations (collectively, “Recoupment Rights”); provided, however, that any amounts recouped or clawed back under any other Recoupment Rights that would be recoupable under this Policy shall count toward any required clawback or recoupment under this Policy and vice versa.

7. Exempt Compensation. Notwithstanding anything to the contrary herein, the Company has no obligation to seek recoupment of amounts paid to a Covered Executive which are granted, vested or earned based solely upon the occurrence or non-occurrence of nonfinancial events. Such exempt compensation includes, without limitation, base salary, time-vesting awards, compensation awarded on the basis of the achievement of metrics that are not Financial Reporting Measures or compensation awarded solely at the discretion of the Committee or the Board, provided that such amounts are in no way contingent on, and were not in any way granted on the basis of, the achievement of any Financial Reporting Measure performance goal.
8.Miscellaneous.

(a)Any applicable award agreement or other document setting forth the terms and conditions of any compensation covered by this Policy shall be deemed to include the restrictions imposed herein and incorporate this Policy by reference and, in the event of any inconsistency, the terms of this Policy will govern. For the avoidance of doubt, this Policy applies to all compensation that is received on or after the Effective Date, regardless of the date on which the award agreement or other document setting forth the terms and conditions of the Covered Executive’s compensation became effective, including, without limitation, compensation received under the Company’s 2022 Omnibus Incentive Plan (as may be amended and restated from time to time) and any successor plan thereto.

(b)This Policy shall be binding and enforceable against all Covered Executives and their beneficiaries, heirs, executors, administrators or other legal representatives.
(c)All issues concerning the construction, validity, enforcement and interpretation of this Policy and all related documents, including, without limitation, any employment agreement, offer letter, equity award agreement or similar agreement, shall be governed by, and construed in accordance with, the laws of the Province of Ontario and the laws of Canada, without giving effect to any choice of law or conflict of law rules or provisions (whether of the Province of Ontario and Canada or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the Province of Ontario and Canada.
(d)The Covered Executives, their beneficiaries, executors, administrators and any other legal representative and the Company shall initially attempt to resolve all claims, disputes or controversies arising under, out of or in connection with this Policy by conducting good faith negotiations amongst themselves. To ensure the timely and economical resolution of disputes that arise in connection with this Policy, any and all disputes, claims or causes of action arising from or relating to the enforcement, performance or interpretation of this Policy shall be resolved to the fullest extent permitted by law by final, binding and confidential arbitration, by a single arbitrator, in Morristown, New Jersey, conducted by Judicial Arbitration and Mediation Services, Inc.

5
    


(“JAMS”) under the applicable JAMS rules. To the fullest extent permitted by law, the Covered Executives, their beneficiaries, executors, administrators and any other legal representative and the Company, shall waive (and shall hereby be deemed to have waived) (1) the right to resolve any such dispute through a trial by jury or judge or administrative proceeding; and (2) any objection to arbitration taking place in Morristown, New Jersey. The arbitrator shall: (i) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (ii) issue a written arbitration decision, to include the arbitrator’s essential findings and conclusions and a statement of the award. The arbitrator shall be authorized to award any or all remedies that any party would be entitled to seek in a court of law. Any such award rendered shall be enforceable by any court having jurisdiction and, to the fullest extent permitted by law, the Covered Executives, their beneficiaries, executors, administrators and any other legal representative and the Company shall waive (and shall hereby be deemed to have waived) the right to resolve any such dispute regarding enforcement of such award through a trial by jury.

(e)Notwithstanding Section 8(d), this Section 8(e) shall apply in respect of Covered Executives who are employed by the Company in Canada. The Covered Executives, their beneficiaries, executors, administrators and any other legal representative and the Company shall initially attempt to resolve all claims, disputes or controversies arising under, out of or in connection with this Policy by conducting good faith negotiations amongst themselves. To ensure the timely and economical resolution of disputes that arise in connection with this Policy, any and all disputes, claims or causes of action arising from or relating to the enforcement, performance or interpretation of this Policy shall be resolved to the fullest extent permitted by law by final, binding and confidential arbitration, through virtual arbitration in accordance with the Arbitration Rules of the ADR Institute of Canada, Inc. To the fullest extent permitted by law, the Covered Executives, their beneficiaries, executors, administrators and any other legal representative and the Company, shall waive (and shall hereby be deemed to have waived) the right to resolve any such dispute through a trial by jury or judge or administrative proceeding. The arbitrator shall: (i) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (ii) issue a written arbitration decision, to include the arbitrator’s essential findings and conclusions and a statement of the award. The arbitrator shall be authorized to award any or all remedies that any party would be entitled to seek in a court of law. Any such award rendered shall be enforceable by any court having jurisdiction and, to the fullest extent permitted by law, the Covered Executives, their beneficiaries, executors, administrators and any other legal representative and the Company shall waive (and shall hereby be deemed to have waived) the right to resolve any such dispute regarding enforcement of such award through a trial by jury. However, the terms of this Section 8(e) shall not apply to any dispute if the subject matter of the dispute is not capable of being the subject of arbitration under applicable law, and nothing in this Section 8(e) shall prevent such Covered Executive from making a report to or filing a claim, application or charge with the applicable governmental or administrative agency or tribunal, and labour relations board (collectively, “administrative agencies”) if the terms of applicable legislation entitles the Covered Executive to do so and precludes exclusive pre-dispute recourse to arbitration. For the avoidance of any doubt, administrative agencies do not include provincial or federal courts. Section 8(e) does not prevent administrative agencies from adjudicating claims and awarding remedies based on those claims, even if the claims would otherwise be covered by this Section 8(e). The Company will not retaliate against the Covered Executive for filing a claim with an administrative agency or for exercising rights in respect of any matter before any administrative agency. Disputes between the Company and any Covered Executive that may not be subject to pre-dispute arbitration agreement, including as provided by applicable legislation, are excluded from the coverage of this Section 8(e).
(f)If any provision of this Policy is determined to be unenforceable or invalid under any applicable law, such provision will be applied to the maximum extent permitted by applicable

6
    


law and shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to any limitations required under applicable law.

7
    

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/21/248-K
For Period end:12/31/23
7/24/23
 List all Filings 


16 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/01/23  Bausch & Lomb Corp.               10-Q        9/30/23  104:11M
 9/29/23  Bausch & Lomb Corp.               8-K:1,2,9   9/29/23   13:3.4M                                   Donnelley … Solutions/FA
 8/02/23  Bausch & Lomb Corp.               10-Q        6/30/23   97:10M
 7/07/23  Bausch & Lomb Corp.               8-K:1,9     6/30/23   11:927K                                   Donnelley … Solutions/FA
 5/03/23  Bausch & Lomb Corp.               10-Q        3/31/23  102:10M
 2/22/23  Bausch & Lomb Corp.               10-K       12/31/22  137:18M
11/02/22  Bausch & Lomb Corp.               10-Q        9/30/22   94:10M
 6/23/22  Bausch & Lomb Corp.               8-K:1,5,9   6/21/22   12:404K                                   Davis Polk & … LLP 01/FA
 5/10/22  Bausch & Lomb Corp.               8-K:1,5,8,9 5/05/22   13:2.4M                                   Donnelley … Solutions/FA
 4/28/22  Bausch & Lomb Corp.               S-1/A                  8:5.8M                                   Donnelley … Solutions/FA
 3/31/22  Bausch & Lomb Corp.               S-1/A                 22:7.3M                                   Donnelley … Solutions/FA
 1/13/22  Bausch & Lomb Corp.               S-1                   16:6M                                     Donnelley … Solutions/FA
 8/03/21  Bausch Health Companies Inc.      10-Q        6/30/21  110:14M
 5/06/19  Bausch Health Companies Inc.      10-Q        3/31/19  110:11M
 3/01/17  Bausch Health Companies Inc.      10-K       12/31/16  150:26M
 4/27/16  Bausch Health Companies Inc.      8-K:5,9     4/21/16    3:453K                                   Skadden/FA
Top
Filing Submission 0001860742-24-000004   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 8:49:49.2am ET